diazoxon has been researched along with Coronary Disease in 2 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mackness, B; Mackness, M | 1 |
| Jelic-Ivanovic, Z; Kalimanovska-Ostric, D; Kotur-Stevuljevic, J; Memon, L; Spasic, S; Spasojevic-Kalimanovska, V; Stefanovic, A; Vujovic, A | 1 |
2 other study(ies) available for diazoxon and Coronary Disease
| Article | Year |
|---|---|
Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease.
Topics: Aryldialkylphosphatase; Case-Control Studies; Coronary Disease; Female; Genotype; Humans; Male; Organophosphorus Compounds; Oxidation-Reduction | 2019 |
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Topics: Aryldialkylphosphatase; Coronary Disease; Female; Humans; Inflammation; Male; Malondialdehyde; Middle Aged; Organophosphorus Compounds; Oxidative Stress; Paraoxon; Phenotype | 2008 |